Global Structural Heart Devices Market Size Study, by Product (Heart Valve Devices, Annuloplasty Rings, Occluders & Delivery Systems, Other Products), by Procedure (Replacement Procedure, Repair Procedure), by End User (Hospitals, Ambulatory Surgical Centers, Cardiac Centers, Others), and Regional Forecasts 2022-2032

February 2025 | 285 pages | ID: GB0143E7B83EEN
Bizwit Research & Consulting LLP

Abstracts

The global structural heart devices market, valued at approximately USD 14.89 billion in 2023, is anticipated to grow with a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2024-2032. Structural heart devices are a specialized category of medical devices designed for diagnosing and treating structural abnormalities in the heart. The rising prevalence of cardiovascular diseases, congenital heart disorders, and associated comorbidities like obesity and hypertension has substantially driven the demand for these devices.

The industry is witnessing transformative growth fueled by advancements in minimally invasive technologies, innovative product designs, and improved procedural techniques. Replacement procedures, particularly transcatheter aortic valve replacement (TAVR), have gained momentum due to their high success rates and minimally invasive nature, enabling shorter recovery periods for patients.

Regional trends highlight North America as the dominant market, propelled by a strong healthcare infrastructure, robust R&D investments, and high adoption rates for advanced medical technologies. Meanwhile, the Asia-Pacific region is expected to exhibit the fastest growth, driven by an aging population, improving healthcare facilities, and increasing awareness of heart-related disorders.

Major players such as Abbott Laboratories, Edwards Lifesciences Corporation, and Boston Scientific Corporation continue to shape the competitive landscape with technological innovations, strategic partnerships, and extensive R&D investments.

Major market players included in this report are:

1. Abbott Laboratories

2. Edwards Lifesciences Corporation

3. Boston Scientific Corporation

4. Medtronic PLC

5. Artivion, Inc.

6. Biomerics

7. JenaValve

8. MicroPort Scientific Corporation

9. Corcym Group

10. Koninklijke Philips NV

11. Lepu Medical Technology (Beijing) Co., Ltd.

12. Tendyne Holdings, Inc.

13. Shandong JW Medical Systems

14. Meril Life Sciences Pvt. Ltd.

15. Xeltis

The detailed segments and sub-segment of the market are explained below:

By Product:

• Heart Valve Devices
• Mechanical Heart Valves
• Tissue Heart Valves
• Transcatheter Heart Valves
• Annuloplasty Rings
• Rigid Annuloplasty Rings
• Flexible Annuloplasty Rings
• Occluders & Delivery Systems
• Atrial Septal Occluders
• Ventricular Septal Occluders
• Left Atrial Appendage Occluders
• Other Products

By Procedure:

• Replacement Procedures
• Transcatheter Aortic Valve Replacement (TAVR)
• Surgical Aortic Valve Replacement (SAVR)
• Repair Procedures
• Mitral Valve Repair
• Annuloplasty
• Other Repair Procedures

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Cardiac Centers
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Years considered for the study are as follows:

Historical year – 2022

Base year – 2023

Forecast period – 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approaches.

Contents

CHAPTER 1. GLOBAL STRUCTURAL HEART DEVICES MARKET EXECUTIVE SUMMARY

1.1. Global Structural Heart Devices Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
  1.3.1. By Product
  1.3.2. By Procedure
  1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

CHAPTER 2. GLOBAL STRUCTURAL HEART DEVICES MARKET DEFINITION AND RESEARCH ASSUMPTIONS

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
  2.3.1. Inclusion & Exclusion
  2.3.2. Limitations
  2.3.3. Supply Side Analysis
    2.3.3.1. Availability
    2.3.3.2. Infrastructure
    2.3.3.3. Regulatory Environment
    2.3.3.4. Market Competition
  2.3.4. Demand Side Analysis
    2.3.4.1. Technological Advancements
    2.3.4.2. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

CHAPTER 3. GLOBAL STRUCTURAL HEART DEVICES MARKET DYNAMICS

3.1. Market Drivers
  3.1.1. Growing Prevalence of Cardiovascular Diseases
  3.1.2. Rising Adoption of Minimally Invasive Procedures
  3.1.3. Favorable Reimbursement Policies
3.2. Market Challenges
  3.2.1. High Cost of Advanced Devices
  3.2.2. Regulatory Compliance Barriers
3.3. Market Opportunities
  3.3.1. Advancements in AI and Big Data in Healthcare
  3.3.2. Emerging Markets in Asia Pacific

CHAPTER 4. GLOBAL STRUCTURAL HEART DEVICES MARKET INDUSTRY ANALYSIS

4.1. Porter’s Five Forces Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
4.2. PESTEL Analysis
  4.2.1. Political
  4.2.2. Economical
  4.2.3. Social
  4.2.4. Technological
  4.2.5. Environmental
  4.2.6. Legal
4.3. Key Investment Opportunities
4.4. Disruptive Trends

CHAPTER 5. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE & FORECAST BY PRODUCT (2024-2032)

5.1. Market Overview
5.2. Heart Valve Devices
  5.2.1. Mechanical Heart Valves
  5.2.2. Tissue Heart Valves
  5.2.3. Transcatheter Heart Valves
5.3. Annuloplasty Rings
  5.3.1. Rigid Annuloplasty Rings
  5.3.2. Flexible Annuloplasty Rings
5.4. Occluders & Delivery Systems
  5.4.1. Atrial Septal Occluders
  5.4.2. Ventricular Septal Occluders
  5.4.3. Left Atrial Appendage Occluders
5.5. Other Products

CHAPTER 6. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE & FORECAST BY PROCEDURE (2024-2032)

6.1. Replacement Procedures
  6.1.1. Transcatheter Aortic Valve Replacement (TAVR)
  6.1.2. Surgical Aortic Valve Replacement (SAVR)
6.2. Repair Procedures
  6.2.1. Mitral Valve Repair
  6.2.2. Annuloplasty
  6.2.3. Other Repair Procedures

CHAPTER 7. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE & FORECAST BY END USER (2024-2032)

7.1. Hospitals
7.2. Ambulatory Surgical Centers
7.3. Cardiac Centers
7.4. Others

CHAPTER 8. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE & FORECAST BY REGION (2024-2032)

8.1. North America
  8.1.1. U.S.
  8.1.2. Canada
8.2. Europe
  8.2.1. UK
  8.2.2. Germany
  8.2.3. France
  8.2.4. Italy
  8.2.5. Spain
  8.2.6. Rest of Europe
8.3. Asia Pacific
  8.3.1. China
  8.3.2. Japan
  8.3.3. India
  8.3.4. Australia
  8.3.5. South Korea
  8.3.6. Rest of Asia Pacific
8.4. Latin America
  8.4.1. Brazil
  8.4.2. Mexico
  8.4.3. Rest of Latin America
8.5. Middle East & Africa
  8.5.1. Saudi Arabia
  8.5.2. South Africa
  8.5.3. Rest of Middle East & Africa

CHAPTER 9. COMPETITIVE INTELLIGENCE

9.1. Key Company SWOT Analysis
  9.1.1. Abbott Laboratories
  9.1.2. Edwards Lifesciences Corporation
  9.1.3. Boston Scientific Corporation
9.2. Competitive Strategies

CHAPTER 10. RESEARCH PROCESS

10.1. Research Framework
10.2. Data Collection Techniques
10.3. Validation Techniques